Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107417726B reveals PC-Phos ligand enabling high-yield asymmetric cyclization. Delivers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN104447610A reveals advanced purification for Ceftazime side-chain acid ensuring high purity and cost reduction in pharmaceutical intermediates manufacturing supply chains.
Patent CN107641122B reveals a scalable crystallization method replacing chromatography, offering high-purity abacavir intermediates with significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN103374050A reveals a cost-effective synthetic route for Scutellarin using KI/KBr catalysis, eliminating toxic heavy metals and ensuring high-purity supply.
Patent CN101417956B details a safer 5-step synthesis for Methoxamine Hydrochloride using methyl p-toluenesulfonate, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN109553629B reveals a photochemical synthesis route for high-purity cefuroxime sodium E-type impurities, offering superior regulatory compliance and supply chain stability.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN113061630A reveals a multi-enzyme cascade for 4-HIL synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN119798229A details high-purity Imatinib Dimer preparation with simplified workflow and scalable yield for pharmaceutical intermediate supply chains.
Patent CN100460389C details a Boc-free intermediate for S-4661, offering simplified purification and reduced metal contamination risks for carbapenem manufacturing.
Patent CN112062829A reveals a hybrid solid-liquid phase synthesis for Elcatonin. Achieve >98% purity and reduced waste for reliable API intermediate manufacturing.
Patent CN105849115B details high-yield synthesis. Offers supply chain stability and cost reduction in API manufacturing for global partners.
Novel pyrrolidine derivative route for Doripenem avoids Boc groups, simplifying purification and reducing costs for pharmaceutical manufacturers.
Patent CN101613280B reveals a high-purity synthesis route for felodipine intermediates using a secondary amine and quinoline carboxylic acid catalyst system, offering significant cost and purity advantages.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103724294A reveals a novel route for Quetiapine intermediates, eliminating high-temperature distillation to ensure superior purity and supply chain stability.
This report analyzes patent CN104961715B for Dapagliflozin production offering reduced impurities and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel preparation method for Gedatolisib intermediates using accessible raw materials. Reduces heavy metal residues and simplifies scale-up for reliable supply chain partners.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Novel photocatalytic route for SC 69124 ensures high purity and supply continuity. Reduces complexity in pharmaceutical intermediates manufacturing for global partners.